查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2092689

非處方藥市場：依產品類型、通路、劑型、年齡層、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測。

Over The Counter Drugs Market, By Product Type, By Distribution Channel, By Formulation Type, By Age Group, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 390 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，非處方藥 (OTC) 市場價值將達到 554.53 億美元，並預計從 2026 年到 2033 年將以 6.5% 的複合年成長率成長。

非處方藥（OTC）是指無需醫生處方箋即可安全服用的藥物。這些藥物可以在醫院、藥局甚至超級市場購買。它們用於治療多種症狀，包括感冒、身體疼痛、過敏、流感、消化不良和痤瘡。由於其易於獲取和使用，成藥已成為日常自我護理和健康管理的重要處方箋部分。

非處方藥市場－市場動態

消費者對自我治療和疾病管理的意識不斷提高，正在推動市場需求。

消費者對自我治療和疾病管理的意識不斷提高，以及越來越多的人選擇使用無需處方箋即可治療多種疾病的非處方藥（OTC），都在推動非處方藥市場的成長。例如，美國國家生物技術資訊中心（NCBI）的一項研究表明，消費者對疾病管理意識的提高以及成藥取得的便利性正在推動醫療保健產業中自我治療的普及。研究發現，全球自我治療率在11.7%至92%之​​間，但印度一項基於社區的調查顯示，60%的成年人自我治療，其中66.3%的人使用止痛藥，59.2%的人使用退燒藥。這很可能成為未來幾年成藥市場成長的主要促進因素。

非處方藥市場－細分分析：

全球非處方藥（OTC）市場按產品類型、分銷管道、劑型、年齡層和地區進行細分。

依產品類型分類，鎮痛藥佔據最大的市場佔有率。這是因為它們被廣泛用於治療各種類型的疼痛，包括頭痛、發燒和肌肉骨骼疼痛。鎮痛藥作為非處方藥（OTC）可透過藥局、雜貨店和其他分銷網路輕鬆購買。 2025年10月，Haleon公司透過推出創新非處方鎮痛藥，例如“Panadol Dual Action”和“Voltaren 2%”，擴展了其鎮痛藥產品線。這種持續的產品創新將有助於非處方鎮痛藥物類別的發展。

由於藥片易於吞嚥、保存期限長、生產成本低，且用途廣泛，可用於各種自我治療，因此在全球非處方藥（OTC）市場中佔據了相當大的佔有率。例如，根據英國政府預測，到2026年，藥品和保健產品監管局（MHRA）已成功完成2025/26會計年度100%的法定績效目標，為英國生命科學領域提供了1000億英鎊的支持。在該會計年度，MHRA查獲了約2,800萬劑非法藥物，加快了藥物和臨床試驗的申請流程，並促進了國際監管合作，以確保患者獲得治療。這些進展進一步鞏固了片劑在全球成藥市場的首選地位。

非處方藥市場—區域分析

北美在成藥）市場佔據顯著佔有率，這得益於處方箋處方藥獲取管道的改善、核准流程的簡化以及零售藥店提供的用於緊急情況和預防保健的成藥。例如，2026年發表在《美國醫學會雜誌網路公開版》（JAMA Network Open）上的一項全國性調查發現，46.0%的美國成年人在過去七天內使用過一種或多種非處方藥，這一比例與處方藥的使用率（46.3%）幾乎相同。這項針對21,000名美國成年人的調查顯示，十大最常用藥物中有六種是非處方藥，包括對乙醯胺酚、Ibuprofen、阿斯匹靈和萘普生。如此高的非處方藥使用率進一步鞏固了北美在全球市場的主導地位。

印度非處方藥市場—各國概況

預計在預測期內，印度成藥）市場將保持高速成長，這主要得益於消費者意識的提高、自我治療的興起以及透過零售和線上管道擴大醫療保健產品的獲取途徑。例如，根據印度政府公共資訊局（PIB）的數據，到2026年3月，總理醫療保健計劃（PMBJP）將透過遍布印度的15,000多個「人民保健中心」（Janaushadi Kendra）提供低價醫療保健產品。 PMBJP舉措提供2000多種優質醫療保健產品，其中包括300種醫療耗材和外科產品。這將減輕醫療保健成本負擔，並使數百萬印度人能夠獲得醫療保健產品。這些措施有望加速成藥的普及，並進一步促進印度市場的成長。

目錄

第1章：非處方藥市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：非處方藥的主要市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：非處方藥產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：非處方藥市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：非處方藥市場狀況

  • 非處方藥市佔率分析，2025年
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 非處方藥市場：依產品類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按產品類型
    • 止痛藥
    • 感冒咳嗽藥
    • 消化和腸道藥物
    • 護膚療程
    • 維生素和礦物質
    • 其他

第8章：非處方藥市場：依劑型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按製劑類型
    • 藥片
    • 膠囊和軟膠囊
    • 液體和糖漿配方
    • 粉末/顆粒
    • 藥膏和乳霜
    • 噴霧劑和吸入器
    • 軟糖/咀嚼片
    • 經皮貼劑

第9章：非處方藥市場：依年齡層別分類

  • 概述
    • 按年齡層分類的市佔率分析
    • 兒童（0-14歲）
    • 成年人（15-64歲）
    • 老年人（65歲以上）

第10章 非處方藥市場：依分銷管道分類

  • 概述
    • 基於細分市場的市場佔有率分析：按分銷管道分類
    • 藥局和零售藥房
    • 醫院藥房
    • 網路藥房

第11章 非處方藥市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第12章：主要供應商分析：非處方藥產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Kenvue
    • Bayer AG
    • Haleon
    • Sanofi SA
    • Reckitt Benckiser Group plc
    • Pfizer Inc.
    • Perrigo Company plc
    • Takeda Pharmaceutical Company Limited
    • Boehringer Ingelheim International GmbH
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Glenmark Pharmaceuticals Ltd.
    • Dr. Reddy's Laboratories Ltd.
    • Procter & Gamble Co.
    • Prestige Consumer Healthcare Inc.
    • Hisamitsu Pharmaceutical Co., Inc.
    • Abbott Laboratories
    • Cipla Ltd.
    • Others

第13章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV6912

Over The Counter Drugs Market size was valued at US$ 55,405.3 Million in 2025, expanding at a CAGR of 6.5% from 2026 to 2033.

The Over-The-Counter (OTC) drugs can be defined as the drugs that have been placed under the category of being quite safe to consume without the need for a prescription from a physician. These kinds of drugs can be accessed from hospitals, medical stores, and even supermarkets without needing any prescription at all. The purpose of consuming such drugs is to treat various diseases, including the common cold, body pain, allergies, flu, indigestion, acne, and so on. Their accessibility and convenience make OTC drugs an essential part of everyday self-care and healthcare management.

Over The Counter Drugs Market- Market Dynamics

Increasing Consumer Awareness of Self-Medication and Disease Management to Propel Market Demand

There is growing consumer awareness about self-medication and disease management, which is contributing to the growth of the Over-the-Counter (OTC) Drug Market because of a growing tendency among many people to use medication that is available for treating different diseases without the necessity of having a prescription. For example, as per the research article in the National Center for Biotechnology Information (NCBI), the use of self-medication is on the rise in the healthcare industry due to the increasing consumer awareness regarding disease management and accessibility of OTC drugs. According to the research paper, the use of self-medication varies across the world from 11.7% to 92%; however, in India, in a community-based study, 60% of adults were observed using the practice of self-medication, whereby 66.3% were using analgesics and 59.2% antipyretics. This will help drive the OTC drugs market in the coming years.

Over The Counter Drugs Market- Segmentation Analysis:

The Global Over The Counter Drugs Market is segmented on the basis of Product Type, Distribution Channel, Formulation Type, Age Group, and Region.

In terms of product type, analgesics have a major market share, as they are commonly used in the treatment of various pains, headaches, fevers, and musculoskeletal pains. They are easily accessible over-the-counter through pharmacies, grocery stores, and other distribution networks. In October 2025, Haleon launched innovative OTC analgesics, including Panadol Dual Action and Voltaren 2%, which would aid in enhancing its collection of pain relief medicines. This continuous product innovation will aid in developing the OTC analgesics category.

The tablets segment holds a prominent share in the global Over The Counter Drugs market due to the reason that the pills are easy to swallow, offer excellent shelf life, are affordable to manufacture, and are popular with customers, as they can be used in a variety of self-medication ways. For instance, in 2026, according to the UK government, the Medicines and Healthcare Products Regulatory Agency (MHRA) successfully managed to deliver 100% of its statutory performance targets during the fiscal year 2025/26 and helped in supporting the £100 billion life sciences sector in the United Kingdom. The MHRA withdrew around 28 million doses of the illegal drug and expedited the medicines and clinical trials applications within the fiscal year, along with encouraging the international regulatory cooperation in order to make the treatments available for the patients. These advancements continue to reinforce tablet formulations as a preferred choice in the global OTC drugs market.

Over The Counter Drugs Market- Geographical Insights

North America holds a significant market share for OTC drugs, aided by increased accessibility to non-prescription medicines, easy approval processes, and availability of OTC medications for emergency and preventive health care from retail pharmacies. For instance, in 2026, as per a nationwide U.S. survey done in the JAMA Network Open journal, 46.0% of adult Americans were seen to use one or more than one over-the-counter (OTC) drugs in the previous seven days, almost equal to the percentage of people using prescription drugs (46.3%). The survey conducted among 21,000 American adults revealed that six of the top ten used drugs were over-the-counter drugs, including acetaminophen, ibuprofen, aspirin, and naproxen. The high usage of OTC drugs keeps strengthening the dominance of North America in the global market.

India Over The Counter Drugs Market- Country Insights

The Indian market of OTC drugs will register a high growth rate over the forecast period because of rising consumer awareness levels, self-medication, and access to healthcare products via retail and online channels. For example, according to the Press Information Bureau (PIB), Government of India, in March 2026, the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) will have provided access to healthcare products at low costs in India through more than 15,000 Jan Aushadhi Kendras. The PMBJP initiative had consisted of more than 2,000 quality healthcare products that included 300 medical consumable and surgical products that have reduced the financial burden of healthcare and provided access to healthcare products for millions of Indians. These initiatives are expected to accelerate OTC drug adoption and strengthen market growth across India.

Over The Counter Drugs Market- Competitive Landscape:

The competitive environment of the over-the-counter (OTC) drug market comprises well-known pharmaceutical firms such as Alkem Laboratories, Bayer, Cipla, Dr Reddy's Laboratories, and Glenmark Pharmaceuticals, which have been working towards increasing their market share through continuous range expansion and market penetration. In December 2025, Cipla formed a partnership with Pfizer India to promote and distribute four brands that consist of the OTC cough syrups Corex DX and Corex LS in the consumer healthcare and OTC drugs segments. This will ensure increased brand presence and growth in the OTC drugs market.

Recent Developments:

In June 2025, Glenmark Therapeutics Inc. launched Olopatadine Hydrochloride Ophthalmic Solution USP 0.2%, an OTC allergy eye drop, further expanding its consumer healthcare and OTC ophthalmic product portfolio.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL OVER THE COUNTER DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Kenvue
  • Bayer AG
  • Haleon
  • Sanofi S.A.
  • Reckitt Benckiser Group plc
  • Pfizer Inc.
  • Perrigo Company plc
  • Takeda Pharmaceutical Company Limited
  • Boehringer Ingelheim International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Procter & Gamble Co.
  • Prestige Consumer Healthcare Inc.
  • Hisamitsu Pharmaceutical Co., Inc.
  • Abbott Laboratories
  • Cipla Ltd.
  • Others

GLOBAL OVER THE COUNTER DRUGS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

  • Analgesics
  • Cold & Cough Remedies
  • Digestives & Intestinal Remedies
  • Skin Treatment
  • Vitamins & Minerals
  • Others

GLOBAL OVER THE COUNTER DRUGS MARKET, BY FORMULATION TYPE- MARKET ANALYSIS, 2020 - 2033

  • Tablets
  • Capsules & Softgels
  • Liquids & Syrups
  • Powders & Granules
  • Ointments & Creams
  • Sprays & Inhalers
  • Gummies & Chewables
  • Transdermal Patches

GLOBAL OVER THE COUNTER DRUGS MARKET, BY AGE GROUP- MARKET ANALYSIS, 2020 - 2033

  • Pediatrics (0-14 yrs)
  • Adults (15-64 yrs)
  • Geriatrics (65+ yrs)

GLOBAL OVER THE COUNTER DRUGS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2020 - 2033

  • Drug Stores & Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

GLOBAL OVER THE COUNTER DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Over The Counter Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
  • 2.2. Competitive Insights

3. Over The Counter Drugs Key Market Trends

  • 3.1. Over The Counter Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Over The Counter Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Over The Counter Drugs Market Opportunities
  • 3.4. Over The Counter Drugs Market Future Trends

4. Over The Counter Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Over The Counter Drugs Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Over The Counter Drugs Market Landscape

  • 6.1. Over The Counter Drugs Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Over The Counter Drugs Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
    • 7.1.2. Analgesics
    • 7.1.3. Cold & Cough Remedies
    • 7.1.4. Digestives & Intestinal Remedies
    • 7.1.5. Skin Treatment
    • 7.1.6. Vitamins & Minerals
    • 7.1.7. Others

8. Over The Counter Drugs Market - By Formulation Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Formulation Type, 2025 & 2033 (%)
    • 8.1.2. Tablets
    • 8.1.3. Capsules & Softgels
    • 8.1.4. Liquids & Syrups
    • 8.1.5. Powders & Granules
    • 8.1.6. Ointments & Creams
    • 8.1.7. Sprays & Inhalers
    • 8.1.8. Gummies & Chewables
    • 8.1.9. Transdermal Patches

9. Over The Counter Drugs Market - By Age Group

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Age Group, 2025 & 2033 (%)
    • 9.1.2. Pediatrics (0-14 yrs)
    • 9.1.3. Adults (15-64 yrs)
    • 9.1.4. Geriatrics (65+ yrs)

10. Over The Counter Drugs Market - By Distribution Channel

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Distribution Channel, 2025 & 2033 (%)
    • 10.1.2. Drug Stores & Retail Pharmacies
    • 10.1.3. Hospital Pharmacies
    • 10.1.4. Online Pharmacies

11. Over The Counter Drugs Market - By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Over The Counter Drugs Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Over The Counter Drugs Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.3.17. Denmark
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Denmark Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Denmark Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Denmark Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.3.18. Rest of Europe
      • 11.3.18.1. Overview
      • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.3.18.5. Rest of the Europe Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.3.18.6. Rest of the Europe Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Over The Counter Drugs Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.4.16. Taiwan
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Taiwan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Taiwan Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Taiwan Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.4.17. Vietnam
      • 11.4.17.1. Overview
      • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.17.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.17.4. Vietnam Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.4.17.5. Vietnam Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.4.17.6. Vietnam Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.4.18. Rest of APAC
      • 11.4.18.1. Overview
      • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.18.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.18.4. Rest of APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.4.18.5. Rest of APAC Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.4.18.6. Rest of APAC Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Over The Counter Drugs Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Over The Counter Drugs Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.6.14. Iran
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Iran Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Iran Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Iran Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.6.15. Qatar
      • 11.6.15.1. Overview
      • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.15.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.15.4. Qatar Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.6.15.5. Qatar Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.6.15.6. Qatar Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)
    • 11.6.16. Rest of MEA
      • 11.6.16.1. Overview
      • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.16.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.16.4. Rest of MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
      • 11.6.16.5. Rest of MEA Market Size and Forecast, By Formulation Type, 2020 - 2033 (US$ Million)
      • 11.6.16.6. Rest of MEA Market Size and Forecast, By Age Group, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Over The Counter Drugs Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Kenvue
    • 12.2.2. Bayer AG
    • 12.2.3. Haleon
    • 12.2.4. Sanofi S.A.
    • 12.2.5. Reckitt Benckiser Group plc
    • 12.2.6. Pfizer Inc.
    • 12.2.7. Perrigo Company plc
    • 12.2.8. Takeda Pharmaceutical Company Limited
    • 12.2.9. Boehringer Ingelheim International GmbH
    • 12.2.10. Sun Pharmaceutical Industries Ltd.
    • 12.2.11. Teva Pharmaceutical Industries Ltd.
    • 12.2.12. Glenmark Pharmaceuticals Ltd.
    • 12.2.13. Dr. Reddy's Laboratories Ltd.
    • 12.2.14. Procter & Gamble Co.
    • 12.2.15. Prestige Consumer Healthcare Inc.
    • 12.2.16. Hisamitsu Pharmaceutical Co., Inc.
    • 12.2.17. Abbott Laboratories
    • 12.2.18. Cipla Ltd.
    • 12.2.19. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us